Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial

Zefei Jiang, Wei Li, Xichun Hu, +22

The Lancet Oncology

Breast OncologyMedicinePharmacologyClinical TrialsBreast Cancer +6

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

Jianming Xu, Yi Li, Qingxia Fan, +33

Nature Communications

Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD‐L1‐positive locally advanced or metastatic non–small‐cell lung cancer: KEYNOTE‐042 China Study

Yi‐Long Wu, Li Zhang, Yun Fan, +14

International Journal of Cancer

Randomized Clinical TrialHealth SciencesMedicineClinical TrialsPathology +11

Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial

Peng Yuan, Xichun Hu, Tao Sun, +11

European Journal of Cancer

Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): a phase III, randomized, double-blind, placebo-controlled study

Binghe Xu, Wei Li, Qingyuan Zhang, +11

Breast Cancer Research and Treatment

Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial

Binghe Xu, Qingyuan Zhang, Tao Sun, +12

BioDrugs

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study

Jin Lu, Weijun Fu, Wei Li, +17

Clinical Lymphoma Myeloma & Leukemia

Safety and efficacy of jaktinib in the treatment of Janus kinase <scp>inhibitor‐naïve</scp> patients with myelofibrosis: Results of a phase <scp>II</scp> trial

Yi Zhang, Hu Zhou, Zhongxing Jiang, +22

American Journal of Hematology

Hematological MalignancyImmunohematologyAntifibrotic TherapyMedicineHematology +12

Efficacy, Safety, and Immunogenicity of HLX04Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatmentfor Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase IIIStudy

Shukui Qin, Jin Li, Yuxian Bai, +13

BioDrugs

Modeling Human Leukemia Immunotherapy in Humanized Mice

Jinxing Xia, Zheng Hu, Satoshi Yoshihara, +7

EBioMedicine

Hematological MalignancyCell TherapyTransplantationMarrow TransplantationLeukemic Hu-mouse Model +13